SHAHRAM NEKOEIAN1, TAHEREH ROSTAMI2, AMIR NOROUZY3, SAFIN HUSSEIN1,4, GHOLAMREZA TAVOOSIDANA1, BAHRAM CHAHARDOULI2, SHAHRBANO ROSTAMI2,*, YAZDAN ASGARI5, ZAHRA AZIZI1,*
Oncology Research, Vol.30, No.6, pp. 259-268, 2022, DOI:10.32604/or.2022.027904
Abstract Acute lymphoblastic leukemia (ALL) is a malignancy of bone marrow lymphoid precursors. Despite effective
treatments, the causes of its progression or recurrence are still unknown. Finding prognostic biomarkers is needed for
early diagnosis and more effective treatment. This study was performed to identify long non-coding RNAs (lncRNAs)
involved in ALL progression by constructing a competitive endogenous RNA (ceRNA) network. These lncRNAs may
serve as potential new biomarkers in the development of ALL. The GSE67684 dataset identified changes in lncRNAs
and mRNAs involved in ALL progression. Data from this study were re-analyzed, and probes related to lncRNAs
were retrieved. Targetscan, miRTarBase,… More >
Login
Register
